Literature DB >> 2159376

Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis.

S Kawata1, K Takaishi, T Nagase, N Ito, Y Matsuda, S Tamura, Y Matsuzawa, S Tarui.   

Abstract

3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and the rate of sterol biosynthesis are positively correlated with DNA synthesis and proliferation of mammalian cells. The total (active plus latent) activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase and the activity of its active form in hepatocellular carcinoma (HCC) from seven patients were measured and compared with those in liver tissue from five control subjects. The activity of the active form in HCC was 61 +/- 21 (SD) pmol/min/mg microsomal protein, while it was only 17 +/- 9.8 pmol/min/mg protein in the liver tissue from the controls; the difference was significant (P less than 0.005). The total activity of the reductase was also higher in HCC although the difference was not significant. The microsomal contents of the enzyme protein also were not significantly different. The rate of cholesterol biosynthesis was 307 +/- 81 pmol/h/mg tissue in HCC and 79.6 +/- 52 in normal liver tissue, indicating a significant increase in the rate in HCC (P less than 0.001). Thus, enhanced synthesis of cholesterol in human HCC seems to result partly from an increase in the active form of the reductase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159376

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  CAAX-box protein, prenylation process and carcinogenesis.

Authors:  Juehua Gao; Jie Liao; Guang-Yu Yang
Journal:  Am J Transl Res       Date:  2009-05-25       Impact factor: 4.060

Review 2.  The effect of statins on cancer cells--review.

Authors:  Lucyna Matusewicz; Justyna Meissner; Monika Toporkiewicz; Aleksander F Sikorski
Journal:  Tumour Biol       Date:  2015-05-23

3.  Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.

Authors:  S R Cerda; J Wilkinson; S K Branch; S A Broitman
Journal:  Lipids       Date:  1999-06       Impact factor: 1.880

4.  [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma.

Authors:  Nicolas Salem; Yu Kuang; David Corn; Bernadette Erokwu; Jeffrey A Kolthammer; Haibin Tian; Chunying Wu; Fangjing Wang; Yanming Wang; Zhenghong Lee
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

5.  Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity.

Authors:  Timothy Miller; Fuquan Yang; Candace E Wise; Fanyin Meng; Sally Priester; Md Kamruzzaman Munshi; Micheleine Guerrier; David E Dostal; Shannon S Glaser
Journal:  Dig Liver Dis       Date:  2011-02-21       Impact factor: 4.088

Review 6.  Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases.

Authors:  Paolo Calabro; Edward T H Yeh
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

Review 7.  Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents.

Authors:  Alfredo Erazo-Oliveras; Natividad R Fuentes; Rachel C Wright; Robert S Chapkin
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

8.  Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial.

Authors:  S Kawata; E Yamasaki; T Nagase; Y Inui; N Ito; Y Matsuda; M Inada; S Tamura; S Noda; Y Imai; Y Matsuzawa
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

9.  NOX1 supports the metabolic remodeling of HepG2 cells.

Authors:  Katharina Bertram; Cristina-Maria Valcu; Michael Weitnauer; Uwe Linne; Agnes Görlach
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

10.  Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).

Authors:  S Kawata; T Nagase; E Yamasaki; H Ishiguro; Y Matsuzawa
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.